Iron deficiency anemia is the most prevalent form of anemia worldwide. In the United States,
clinicians routinely screen for iron deficiency anemia upon initiation of prenatal care, at the …

Background optimal management of end-stage renal disease (ESRD) in hemodialysis (HD)
patients should be more studied because it is a serious risk factor for mortality, being …

Background and Objectives: Iron deficiency and anemia characterize patients on chronic
hemodialysis (HD). Available intravenous iron agents, such as ferric gluconate (FG) and …

Introduction Patients with chronic kidney disease on hemodialysis (HD) are at high risk of
developing both iron deficiency and iron deficiency anemia (IDA). The administration of …

The effectiveness of reticulocyte hemoglobin content (CHr) had been reported to detect early
functional iron deficiency especially among Chronic kidney disease (CKD) patients. CHr is …

Iron Metabolism and Iron Therapy in Chronic Renal Failure - GIN Skip to content GIN
Italiano (it) English (en) Accedi Cerca Contenuti dal Menu ARCHIVE EDITORIAL BOARD …

Background Intravenous iron sucrose is becoming a prevailing treatment for individuals
undergoing maintenance haemodialysis, but comparisons of dosing regimens are lacking …

Introducción: la medición del factor de anemia microcítica (Maf®) es rápida y rentable.
Diversos estudios demuestran su utilidad en el estudio del metabolismo del hierro, sin …

ABSTRACT Background: Chronic Kidney Disease (CKD) is a global health problem and
associated with increased morbidity and mortality. Hemodialysis is the most common mode …

Хемодиализното лечение (ХД) представлява най-често срещаната форма на
бъбречнозаместваща терапия (БЗТ) при пациенти с терминален стадий на хронично …